Zions Bancorporation, N.A. Nektar Therapeutics Transaction History

Zions Bancorporation, N.A.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$15.87 - $23.12 $968 - $1,410	-61 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$16.91 - $36.27 $135 - $290	8 Added 15.09%	61 $1,000
Q2 2019 Jul 09, 2019	SELL	$31.0 - $36.3 $2,356 - $2,758	-76 Reduced 58.91%	53 $2,000
Q1 2019 May 10, 2019	BUY	$31.58 - $46.35 $4,073 - $5,979	129 New	129 $4,000

146

139M

32.6K

14.1K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $212M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Zions Bancorporation, N.A., based on Form 13F filings with the SEC.

Stay updated on Zions Bancorporation, N.A. with notifications on news.